SCHEMBL15528328

SCHEMBL15528328

CCOC(=O)c1c(O)c2cc(-c3cccc(OC)n3)cnc2n(O)c1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.41
KDM4E B2RXH2 6/20 0.41
RECQL P46063 1/20 0.39
TGFBR1 P36897 2/20 0.39
LMNA P02545 2/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
METAP2 P50579 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HTT P42858 1/20 0.37
TP53 P04637 1/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
CCR6 P51684 1/20 0.36
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15528220 0.86 KDM4E (0.41) ALDH1A1KDM4ERECQLTGFBR1LMNA
SCHEMBL3517668 0.83 KDM4E (0.48) ALDH1A1KDM4ERECQLTP53HPGD
SCHEMBL16594575 0.83 ALDH1A1 (0.39) ALDH1A1KDM4ERECQLTGFBR1LMNA
SCHEMBL3519481 0.82 KDM4E (0.51) ALDH1A1KDM4ERECQLLMNASMN1; SMN2
SCHEMBL3519310 0.82 KDM4E (0.44) ALDH1A1KDM4ERECQLLMNACA12
SCHEMBL3518359 0.82 KDM4E (0.48) ALDH1A1KDM4ERECQLLMNASMN1; SMN2
SCHEMBL3516004 0.81 ALOX5 (0.48) ALDH1A1KDM4ERECQLLMNA
SCHEMBL3517888 0.79 ALDH1A1 (0.42) ALDH1A1KDM4ERECQLLMNASMN1; SMN2
SCHEMBL3514731 0.79 KDM5A (0.43) ALDH1A1KDM4ERECQLLMNASMN1; SMN2
SCHEMBL3516008 0.78 EGLN1 (0.42) ALDH1A1KDM4ERECQLSMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150094327-A1 COMPOSITIONS AND METHODS FOR INHIBITING RESOLVASES NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR 2015-04-02 US disclosed
US-20150093356-A1 THROMBOPOIETIN MIMETICS GLAXOSMITHKLINE LLC 2015-04-02 US disclosed
US-20150094327-A1 COMPOSITIONS AND METHODS FOR INHIBITING RESOLVASES NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR 2015-04-02 US disclosed
US-20150094327-A1 COMPOSITIONS AND METHODS FOR INHIBITING RESOLVASES NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR 2015-04-02 US disclosed
WO-2013165898-A2 COMPOSITIONS AND METHODS FOR INHIBITING RESOLVASES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2013-11-07 WO disclosed
WO-2013165898-A2 COMPOSITIONS AND METHODS FOR INHIBITING RESOLVASES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2013-11-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150093356-A1 THROMBOPOIETIN MIMETICS MPL, THPO, TEK ALDH1A1 1012/4885KDM4E 3202/4885RECQL 3970/4885
US-20150094327-A1 COMPOSITIONS AND METHODS FOR INHIBITING RESOLVASES FEN1, RCE1, APEX1 ALDH1A1 4188/4885KDM4E 1800/4885RECQL 567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.